Covered recipient · General Payments record
KELTY R BAKER
Allopathic & Osteopathic Physicians Internal Medicine Hematology
General Payments · PY2018–2024
$252,902.88
- Reported across 551 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $2,783.00 | 4 |
| Food and Beverage | $1,046.94 | 36 |
| Consulting Fee | $300.00 | 1 |
| Education | $30.29 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $2,283.00 | 1 |
| Acerta Pharma LLC | $500.00 | 3 |
| Celgene Corporation | $421.23 | 6 |
| Agios Pharmaceuticals, Inc. | $123.74 | 1 |
| Apellis Pharmaceuticals, Inc. | $119.81 | 3 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $95.13 | 3 |
| BeiGene USA, Inc. | $82.42 | 4 |
| ABBVIE INC. | $57.27 | 2 |
| PharmaEssentia USA Corporation | $49.94 | 2 |
| Takeda Pharmaceuticals U.S.A., Inc. | $49.34 | 2 |
| GENZYME CORPORATION | $44.14 | 2 |
| SOBI, INC | $43.18 | 1 |
| Alexion Pharmaceuticals, Inc. | $32.31 | 1 |
| Amgen Inc. | $31.02 | 1 |
| Rigel Pharmaceuticals, Inc. | $30.18 | 1 |
| Blueprint Medicines Corporation | $28.10 | 1 |
| Incyte Corporation | $26.78 | 1 |
| GlaxoSmithKline, LLC. | $26.11 | 1 |
| RECORDATI_RARE_DISEASES_INC. | $23.25 | 1 |
| SECURA BIO, INC. | $22.84 | 1 |
| Lilly USA, LLC | $22.29 | 1 |
| GE HEALTHCARE | $19.23 | 1 |
| Janssen Pharmaceuticals, Inc | $14.63 | 1 |
| PFIZER INC. | $14.29 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (42)
Sorted by paying entity, then date · as published by CMS
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.